[TNXP] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[TNXP] Tonix Pharmaceuticals Holding Corp.
Announcement Date
09-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 1.34%
YoY- 3.47%
Quarter Report
TNXP's Result
TNXP's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 2,208 2,482 3,779 3,989 0 33,902 0 -
PBT -78,776 -14,939 -27,322 -27,975 -28,356 -33,005 -31,680 83.64%
Tax 0 -1,210 -0 -1,216 29,002 -1,790 5,611 -
NP -78,776 -14,939 -27,322 -27,975 -28,356 -33,005 -34,084 74.89%
Tax Rate - - - - - - - -
Total Cost 80,984 17,421 31,101 31,964 28,356 66,907 34,084 78.15%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -3,567.75 -601.89 -723.00 -701.30 0.00 -100.00 0.00 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -19.28 -5.91 -27.53 -58.40 -85.71 -102.85 -111.06 -68.91%
EPS Diluted -19.28 -5.91 -27.53 -58.40 -85.71 -102.85 -111.06 -68.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.